FAIRsharing is here! From our first incarnation, BioSharing.org, which focussed on the life sciences, we are growing into FAIRsharing.org, to serve users across all disciplines and support Findable, Accessible, Interoperable and Reusable (FAIR) data.
Standards > reporting guideline > bsg-s000679

ready Minimum Information About a Cellular Assay for Regenerative Medicine


General Information
Currently, there are more than 20 human cell information storage sites around the world. However, reproducibility and data exchange among different laboratories or cell information providers are usually inadequate or nonexistent because of the lack of a standardized format for experiments. This study, which is the fruit of collaborative work by scientists at stem cell banks and cellular information registries worldwide, including those in the U.S., the U.K., Europe, and Japan, proposes new minimum information guidelines, Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), for cellular assay data deposition. MIACARM was developed based on the existing guideline called MIACA. MIACARM is intended to promote data exchange and facilitation of practical regenerative medicine.

This record is maintained by KSakurai

Record added: Oct. 11, 2016, 10:02 a.m.
Record updated: Oct. 14, 2016, 3:26 a.m. by KSakurai.


No support information provided.

Additional Information


    No tools defined


No XSD schemas defined

Access / Retrieve Data

Conditions of Use

Related Standards

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Implementing Databases (0)

No Related Databases

Implementing Policies

This record is not implemented by any policy.


Record Maintainer



First proposal of Minimum Information About a Cellular Assay for Regenerative Medicine

Kunie Sakurai, Andreas Kurtz, Glyn Stacey, Michael Sheldon, and Wataru Fujibuchi
Stem Cells Translational Medicine 2016

View Paper (PubMed) View Paper (DOI)